Doxycycline and Autogenous Bone in Repair of Critical-Size Defects

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Surgical Innovation

Background:

• Critical-size bone defects pose significant clinical challenges.
• Autogenous bone grafts are a gold standard but have limitations.
• Doxycycline's potential role in bone regeneration requires further investigation.

Purpose of the Study:

• To evaluate the efficacy of combining doxycycline (DOX) with autogenous bone for repairing critical-size bone defects.
• To compare this combination therapy against control, doxycycline alone, and autogenous bone alone.

Main Methods:

• Fifty rats with critical-size defects received one of five treatments: control, doxycycline in Natrosol gel, Natrosol gel, particulate autogenous bone (PAB), or PAB + doxycycline gel.
• Histomorphometric analysis assessed new bone formation at 4 and 8 weeks.
• Statistical analysis utilized ANOVA and Tukey's test.

Main Results:

• The PAB + DOX group demonstrated significantly higher new bone formation (38.59% at 4 weeks, 47.86% at 8 weeks) compared to controls.
• Significant improvements were observed against control, doxycycline alone, and Natrosol gel groups at 8 weeks.

Conclusions:

• The combination of doxycycline and autogenous bone significantly enhances bone healing in critical-size defects.
• This synergistic effect suggests a promising therapeutic strategy for bone regeneration.